NCT04510220
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- Brigham MS Center, 60 Fenwood Road Boston, Massachusetts, United States
Clinical trial condition
Relapsing Multiple Sclerosis
Explore clinical trials studying Relapsing Multiple Sclerosis. Study availability and eligibility vary by location and protocol.
69 public trials
9 recruiting studies
Relapsing Multiple Sclerosis trial results
NCT04486716
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- Alabama Neurology Associates PC Birmingham, Alabama, United States
- Ctr for Neurology and Spine Phoenix, Arizona, United States
- Neuro Center Pomona, California, United States
- UC Health Neuroscience Ctr Aurora, Colorado, United States
Completed
Study of Efficacy and Safety of Ofatumumab in Relapsing Multiple Sclerosis (RMS) Patients in China
NCT05199571
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- Novartis Investigative Site Lanzhou, Gansu, China
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Guangzhou, Guangdong, China
- Novartis Investigative Site Guangzhou, Guangdong, China
NCT03996291
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- North Central Neurology Associates, PC Site Number : 8400005 Cullman, Alabama, United States
- Neurology Associates, PA Site Number : 8400002 Maitland, Florida, United States
- University of South Florida Site Number : 8400009 Tampa, Florida, United States
- Velocity Clinical Research Site Number : 8400007 Savannah, Georgia, United States
NCT03889639
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- Investigational Site Number 8400005 Cullman, Alabama, United States
- Investigational Site Number 8400002 Maitland, Florida, United States
- Investigational Site Number 8400004 Sunrise, Florida, United States
- Investigational Site Number 8400009 Tampa, Florida, United States
NCT05266469
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- Novartis Investigative Site Al Ain Abu Dhabi, United Arab Emirates
- Novartis Investigative Site Sharjah city, United Arab Emirates
- Novartis Investigative Site Abu Dhabi, United Arab Emirates
- Novartis Investigative Site Abu Dhabi, United Arab Emirates
NCT04410978
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- University of Alabama MS Center-Site Number:8400013 Birmingham, Alabama, United States
- University of San Francisco, Sandler Neurosciences Center-Site Number:8400137 San Francisco, California, United States
- University of Colorado-Site Number:8400012 Aurora, Colorado, United States
- Georgetown University Medical Center-Site Number:8400119 Washington D.C., District of Columbia, United States
NCT04410991
- Conditions
- Relapsing Multiple Sclerosis
- Locations
-
- North Central Neurology Associates, PC-Site Number:8400009 Cullman, Alabama, United States
- Center for Neurology and Spine-Site Number:8400089 Phoenix, Arizona, United States
- Arcadia Neurology Center-Site Number:8400070 Arcadia, California, United States
- Multiple Sclerosis Center of California-Site Number:8400135 Newport Beach, California, United States
NCT04869358
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
- Locations
-
- Novartis Investigative Site Berlin, Germany
- Novartis Investigative Site Bielefeld, Germany
- Novartis Investigative Site Dresden, Germany
- Novartis Investigative Site Erbach im Odenwald, Germany
NCT04121403
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
- Locations
-
- Department of Neurology - Drammen, Vestre Viken HF Drammen, Buskerud, Norway
- Department of Neurology - Lillehammer, SI Lillehammer Lillehammer, Oppland, Norway
- Department of Neurology, Stavanger universitetssykehus Stavanger, Rogaland, Norway
- Department of Neurology - Førde, Helse Førde HF Førde, Sogn Og Fjordane, Norway